Figure 5. KDT501 reduces body fat and improves glucose metabolism.

The test compounds were given orally twice daily for a month. Oral glucose tolerance test (OGTT) conducted as described in methods; glucose (A), insulin (B), glucose AUC (C) and insulin AUC (D) levels were presented. Body fat as determined by QNMR at the end of the study were presented (E). Data expressed as Mean ±SEM. * Mean values significantly different from vehicle control group (p<0.05).